Details
Stereochemistry | |
Molecular Formula | 5CN.Fe.NO |
Molecular Weight | 215.938 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | -2 |
SHOW SMILES / InChI
SMILES
[Fe++].[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.N#[O+]
InChI
InChIKey=YEESUBCSWGVPCE-UHFFFAOYSA-N
InChI=1S/5CN.Fe.NO/c5*1-2;;1-2/q5*-1;+2;+1
Nitroprusside is a medication which is used to lower blood pressure. It is comprised of a ferrous ion complexed with five cyanide and one nitrosyl group. Upon intravenous infusion, nitroprusside interacts with oxyhemoglobin and dissociates, releasing cyanide and nitric oxide, which act as a powerful vasodilating agent. Sodium nitroprusside was approved by the FDA in 1974 and is indicated for the immediate reduction of blood pressure of adult and pediatric patients in hypertensive crises. Sodium Nitroprusside injection is also indicated for producing controlled hypotension in order to reduce bleeding during surgery, and for the treatment of acute congestive heart failure.
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | NIPRIDE Approved UseSodium Nitroprusside injection is indicated for the immediate reduction of blood pressure of adult and pediatric patients in hypertensive crises. Concomitant longer-acting antihypertensive medication should be administered so that the duration of treatment with Sodium Nitroprusside can be minimized. Sodium Nitroprusside injection is also indicated for producing controlled hypotension in order to reduce bleeding during surgery. Sodium Nitroprusside injection is also indicated for the treatment of acute congestive heart failure. Launch Date1.50076801E11 |
|||
Primary | NIPRIDE Approved UseSodium Nitroprusside injection is indicated for the immediate reduction of blood pressure of adult and pediatric patients in hypertensive crises. Concomitant longer-acting antihypertensive medication should be administered so that the duration of treatment with Sodium Nitroprusside can be minimized. Sodium Nitroprusside injection is also indicated for producing controlled hypotension in order to reduce bleeding during surgery. Sodium Nitroprusside injection is also indicated for the treatment of acute congestive heart failure. Launch Date1.50076801E11 |
Overview
CYP3A4 | CYP2C9 | CYP2D6 | hERG |
---|---|---|---|
OverviewOther
Other Inhibitor | Other Substrate | Other Inducer |
---|---|---|
Drug as perpetrator
Target | Modality | Activity | Metabolite | Clinical evidence |
---|---|---|---|---|
Page: abstract |
no | |||
Sources: https://link.springer.com/article/10.1007/BF00497774 Page: abstract |
yes | |||
Page: abstract |
yes | |||
Page: abstract |
yes | |||
Sources: https://www.nature.com/articles/aps201225 Page: abstract |
yes |
PubMed
Title | Date | PubMed |
---|---|---|
Venodilator effects of adenosine triphosphate and sodium nitroprusside; comparisons during controlled hypotension. | 1987 Sep 1 |
|
Features of the acute hypotensive action of carvedilol and its ameliorating effect on myocardial ischemia. | 1991 |
|
Blood pressure, pulse, and neurohumoral responses to nitroprusside-induced hypotension in normotensive aging men. | 1991 Jul |
|
Comparative cardiovascular effects of SNP, ATP and phentolamine during norepinephrine-induced hypertension in dogs. | 1991 Oct |
|
Effect of hypotension and hyperosmolality on vasopressin and ACTH responses to hypoglycemia in conscious dogs. | 1992 Aug |
|
Bradykinin-induced activation of nociceptors: receptor and mechanistic studies on the neonatal rat spinal cord-tail preparation in vitro. | 1992 Dec |
|
Cardiovascular function during induced hypotension by fenoldopam or sodium nitroprusside in anesthetized dogs. | 1992 Jan |
|
Temporary blindness due to sodium nitroprusside overdosage in a postoperative patient: an unusual adverse effect. | 1992 Jun |
|
Inhibition of inducible nitric oxide synthase in the human intestinal epithelial cell line, DLD-1, by the inducers of heme oxygenase 1, bismuth salts, heme, and nitric oxide donors. | 2000 Dec |
|
NO-dependent vasorelaxation is impaired after gene transfer of inducible NO-synthase. | 2001 Aug |
|
Comparison of the effects of nitric oxide, nitroprusside, and nifedipine on hemodynamics and right ventricular contractility in patients with chronic pulmonary hypertension. | 2001 Jan |
|
Catalepsy and hypolocomotion induced by a nitric oxide donor: attenuation by theophylline. | 2001 Nov 30 |
|
Short-term histopathologic effects of different intracavernosal agents on corpus cavernosum and antifibrotic activity of intracavernosal verapamil: an experimental study. | 2001 Sep |
|
Stimulus-dependence of NO-mediated neuronal activation: a Fos expression study in the hippocampus and cortex of lactating rats. | 2001 Sep 17 |
|
Serotonin(3) receptor stimulation in the nucleus tractus solitarii activates non-catecholaminergic neurons in the rat ventrolateral medulla. | 2002 |
|
Hypotension-induced dopamine release in prefrontal cortex is mediated by local glutamatergic projections at the level of nerve terminals. | 2002 Apr |
|
Acute sympathoexcitatory action of angiotensin II in conscious baroreceptor-denervated rats. | 2002 Aug |
|
Neurochemistry of nerve fibers apposing sympathetic preganglionic neurons activated by sustained hypotension. | 2002 Aug 5 |
|
Elevated vascular resistance after labetalol during resection of a pheochromocytoma (brief report). | 2002 Feb |
|
Myocardial tissue oxygen during coronary artery constriction and hypotension in dogs. | 2002 Jul |
|
Sodium nitroprusside-induced, but not desflurane-induced, hypotension decreases myocardial tissue oxygenation in dogs anesthetized with 8% desflurane. | 2002 Jun |
|
Increased baroreceptor response in mice deficient in monoamine oxidase A and B. | 2002 Mar |
|
Ginkgolide A, B, and huperzine A inhibit nitric oxide-induced neurotoxicity. | 2002 Oct |
|
Withdrawal reveals lack of effect of prolonged antihypertensive treatment on intrinsic aortic wall stiffness in senescent spontaneously hypertensive rats. | 2002 Oct |
|
Internal thoracic artery flow competition: studies in a canine H-graft model. | 2003 Jan |
|
A-350619: a novel activator of soluble guanylyl cyclase. | 2003 Jan 17 |
|
Cocaine- and amphetamine-regulated transcript is present in hypothalamic neuroendocrine neurones and is released to the hypothalamic-pituitary portal circuit. | 2003 Mar |
|
Differential toxicity of nitric oxide, aluminum, and amyloid beta-peptide in SN56 cholinergic cells from mouse septum. | 2003 Mar |
|
Relationships and distinctions in iron-regulatory networks responding to interrelated signals. | 2003 May 1 |
|
Receptor activity modifying protein 2 distribution in the rat central nervous system and regulation by changes in blood pressure. | 2003 Sep |
|
Esmolol attenuates hepatic blood flow responses during sodium nitroprusside-induced hypotension in dogs. | 2004 Apr |
|
Nitric oxide donor sodium nitroprusside dilates rat small arteries by activation of inward rectifier potassium channels. | 2004 Apr |
|
Intrapericardial delivery enhances cardiac effects of sotalol and atenolol. | 2004 Jul |
|
Effects of TNF-alpha and IFN-gamma on nitric oxide-induced neurotoxicity in the mouse brain. | 2004 Jun 1 |
|
Down-regulation of survivin in nitric oxide-induced cell growth inhibition and apoptosis of the human lung carcinoma cells. | 2004 May 7 |
|
The inhibitory effect of sodium nitroprusside on HIF-1 activation is not dependent on nitric oxide-soluble guanylyl cyclase pathway. | 2004 Nov 5 |
|
Regulation of cytoplasmic stress granules by apoptosis-inducing factor. | 2004 Sep 1 |
|
Intracavernous sodium nitroprusside (SNP) versus papaverine/phentolamine in erectile dysfunction: a comparative study of short-term efficacy and side-effects. | 2005 Jan |
|
Dynamic beat-to-beat modeling of the QT-RR interval relationship: analysis of QT prolongation during alterations of autonomic state versus human ether a-go-go-related gene inhibition. | 2005 Jan |
|
Effect of nitric oxide on mitogen-activated protein kinases in neonatal pulmonary vascular smooth muscle. | 2005 Sep-Oct |
|
NMDA receptor-nitric oxide transmission mediates neuronal iron homeostasis via the GTPase Dexras1. | 2006 Aug 17 |
|
Hypoxia-mimetic agents desferrioxamine and cobalt chloride induce leukemic cell apoptosis through different hypoxia-inducible factor-1alpha independent mechanisms. | 2006 Jan |
|
Iron released by sodium nitroprusside contributes to heme oxygenase-1 induction via the cAMP-protein kinase A-mitogen-activated protein kinase pathway in RAW 264.7 cells. | 2006 May |
|
S-nitrosylation of Bcl-2 inhibits its ubiquitin-proteasomal degradation. A novel antiapoptotic mechanism that suppresses apoptosis. | 2006 Nov 10 |
|
Ablation of NK1 receptor bearing neurons in the nucleus of the solitary tract blunts cardiovascular reflexes in awake rats. | 2006 Nov 13 |
|
Acrylamide analog as a novel nitric oxide-independent soluble guanylyl cyclase activator. | 2006 Oct |
|
Cytotoxicity of nitric oxide is alleviated by zinc-mediated expression of antioxidant genes. | 2006 Oct |
|
Phenotype-dependent susceptibility of cholinergic neuroblastoma cells to neurotoxic inputs. | 2006 Sep |
|
Melittin inhibits inflammatory target gene expression and mediator generation via interaction with IkappaB kinase. | 2007 Jan 15 |
|
Compromised aortic vasoreactivity in male estrogen receptor-alpha-deficient mice during acute lipopolysaccharide-induced inflammation. | 2007 Mar |
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29707
Created by
admin on Wed Jul 05 23:04:28 UTC 2023 , Edited by admin on Wed Jul 05 23:04:28 UTC 2023
|
||
|
LIVERTOX |
NBK548613
Created by
admin on Wed Jul 05 23:04:28 UTC 2023 , Edited by admin on Wed Jul 05 23:04:28 UTC 2023
|
||
|
NCI_THESAURUS |
C1937
Created by
admin on Wed Jul 05 23:04:28 UTC 2023 , Edited by admin on Wed Jul 05 23:04:28 UTC 2023
|
||
|
FDA ORPHAN DRUG |
112498
Created by
admin on Wed Jul 05 23:04:28 UTC 2023 , Edited by admin on Wed Jul 05 23:04:28 UTC 2023
|
||
|
WHO-ATC |
C02DD01
Created by
admin on Wed Jul 05 23:04:28 UTC 2023 , Edited by admin on Wed Jul 05 23:04:28 UTC 2023
|
||
|
WHO-VATC |
QC02DD01
Created by
admin on Wed Jul 05 23:04:28 UTC 2023 , Edited by admin on Wed Jul 05 23:04:28 UTC 2023
|
||
|
NDF-RT |
N0000175940
Created by
admin on Wed Jul 05 23:04:28 UTC 2023 , Edited by admin on Wed Jul 05 23:04:28 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000079999
Created by
admin on Wed Jul 05 23:04:28 UTC 2023 , Edited by admin on Wed Jul 05 23:04:28 UTC 2023
|
PRIMARY | |||
|
Nitroprusside
Created by
admin on Wed Jul 05 23:04:28 UTC 2023 , Edited by admin on Wed Jul 05 23:04:28 UTC 2023
|
PRIMARY | |||
|
169D1260KM
Created by
admin on Wed Jul 05 23:04:28 UTC 2023 , Edited by admin on Wed Jul 05 23:04:28 UTC 2023
|
PRIMARY | |||
|
DB00325
Created by
admin on Wed Jul 05 23:04:28 UTC 2023 , Edited by admin on Wed Jul 05 23:04:28 UTC 2023
|
PRIMARY | |||
|
7596
Created by
admin on Wed Jul 05 23:04:28 UTC 2023 , Edited by admin on Wed Jul 05 23:04:28 UTC 2023
|
PRIMARY | |||
|
4631
Created by
admin on Wed Jul 05 23:04:28 UTC 2023 , Edited by admin on Wed Jul 05 23:04:28 UTC 2023
|
PRIMARY | |||
|
Nitroprusside
Created by
admin on Wed Jul 05 23:04:28 UTC 2023 , Edited by admin on Wed Jul 05 23:04:28 UTC 2023
|
PRIMARY | |||
|
169D1260KM
Created by
admin on Wed Jul 05 23:04:28 UTC 2023 , Edited by admin on Wed Jul 05 23:04:28 UTC 2023
|
PRIMARY | |||
|
124081848
Created by
admin on Wed Jul 05 23:04:28 UTC 2023 , Edited by admin on Wed Jul 05 23:04:28 UTC 2023
|
PRIMARY | |||
|
D009599
Created by
admin on Wed Jul 05 23:04:28 UTC 2023 , Edited by admin on Wed Jul 05 23:04:28 UTC 2023
|
PRIMARY | |||
|
DTXSID2046963
Created by
admin on Wed Jul 05 23:04:28 UTC 2023 , Edited by admin on Wed Jul 05 23:04:28 UTC 2023
|
PRIMARY | |||
|
7476
Created by
admin on Wed Jul 05 23:04:28 UTC 2023 , Edited by admin on Wed Jul 05 23:04:28 UTC 2023
|
PRIMARY | RxNorm | ||
|
SUB14660MIG
Created by
admin on Wed Jul 05 23:04:28 UTC 2023 , Edited by admin on Wed Jul 05 23:04:28 UTC 2023
|
PRIMARY | |||
|
15078-28-1
Created by
admin on Wed Jul 05 23:04:28 UTC 2023 , Edited by admin on Wed Jul 05 23:04:28 UTC 2023
|
PRIMARY | |||
|
C77153
Created by
admin on Wed Jul 05 23:04:28 UTC 2023 , Edited by admin on Wed Jul 05 23:04:28 UTC 2023
|
PRIMARY |
ACTIVE MOIETY